The Food and Drug Administration has updated labels for popular weight loss drugs like Ozempic and Wegovy. NFL News: ...
FDA's Human Foods Program released its 2025 Priority Deliverables today, which details the primary focuses for its first year under the reorganization. Highlights include a goal to issue guidance on ...
The U.S. Food and Drug Administration's recall concerns two butter products produced by Continental Dairy ...
The harm done by ultra-processed foods — those that have so many additives and have undergone so much processing they're far ...
Let’s face it, cooking every day can be a hassle, so it’s no surprise millions of Americans use meal-prep companies to save ...
On November 5, the US Food and Drug Administration (FDA) updated the labels for all glucagon-like peptide 1 receptor agonists (GLP-1 RA) with a warning about pulmonary aspiration during general ...
The transition period between when voters select a presidential candidate and when that person takes office “is almost ...
The FDA has updated the labels for all GLP-1 receptor agonists, including popular medications Ozempic, Wegovy, Saxenda and Mounjaro, to include a new warning about the risk of pulmonary aspiration ...
It features a customized vitamin assessment and proprietary algorithm, access to Persona's proprietary Drug-Nutrient ... learn more about Persona Nutrition's white-labeling program, visit ...
Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...
For those patients, there have been some rare cases of pulmonary aspiration — or inhaling fluid or food into the lungs — ...